PJSIMP
REGN icon

P.J. Schmidt Investment Management (PJS)’s Regeneron Pharmaceuticals REGN Stock Holding History

P.J. Schmidt Investment Management (PJS)’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-813
Closed -$306K – 135
2017
Q4 		$306K Sell
813
-300
-27% -$122K 0.09% 110
2017
Q3 		$498K Buy
1,113
+100
+10% +$47.6K 0.15% 95
2017
Q2 		$498K Sell
1,013
-60
-6% -$26.3K 0.15% 91
2017
Q1 		$416K Sell
1,073
-145
-12% -$53.7K 0.15% 96
2016
Q4 		$447K Sell
1,218
-156
-11% -$59.3K 0.17% 92
2016
Q3 		$552K Sell
1,374
-5
-0.4% -$2.01K 0.21% 91
2016
Q2 		$482K Sell
1,379
-140
-9% -$53.9K 0.18% 97
2016
Q1 		$548K Sell
1,519
-71
-4% -$29.3K 0.22% 95
2015
Q4 		$863K Buy
1,590
+10
+0.6% +$5.42K 0.35% 80
2015
Q3 		$735K Buy
1,580
+50
+3% +$26.9K 0.32% 90
2015
Q2 		$780K Sell
1,530
-8
-0.5% -$3.9K 0.31% 92
2015
Q1 		$694K Buy
1,538
+393
+34% +$167K 0.27% 95
2014
Q4 		$470K Buy
1,145
+15
+1% +$5.9K 0.19% 107
2014
Q3 		$407K Hold
1,130
– – 0.17% 114
2014
Q2 		$319K Sell
1,130
-20
-2% -$5.93K 0.12% 127
2014
Q1 		$345K Hold
1,150
– – 0.14% 120
2013
Q4 		$317K Buy
+1,150
New +$331K 0.13% 110

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

P.J. Schmidt Investment Management (PJS)'s REGN Position: Q1 2018 in Review

P.J. Schmidt Investment Management (PJS) sold out of Regeneron Pharmaceuticals (REGN) in Q1 2018, closing a stake of 813 shares — an estimated $306K sold.

P.J. Schmidt Investment Management (PJS) first reported a position in REGN in Q4 2013 and held it in 17 quarters. The position peaked at $863K in Q4 2015. 619 funds tracked by Wall St. Rank hold REGN as of Q1 2018.

  • P.J. Schmidt Investment Management (PJS) reported no remaining Regeneron Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
  • P.J. Schmidt Investment Management (PJS) sold 813 Regeneron Pharmaceuticals shares in Q1 2018, an estimated $306K.
  • P.J. Schmidt Investment Management (PJS) first reported a position in Regeneron Pharmaceuticals in Q4 2013 and held it in 17 quarters.
  • P.J. Schmidt Investment Management (PJS)'s Regeneron Pharmaceuticals position peaked at $863K in Q4 2015.
  • 619 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2018.

Based on P.J. Schmidt Investment Management (PJS)'s 13F filing for Q1 2018, filed 24 Apr 2018.